European consensus table 2006 on botulinum toxin for children with cerebral palsy.
An interdisciplinary group of experienced botulinum toxin users and experts in the field of movement disorders was assembled, to develop a consensus on best practice for the treatment of cerebral palsy using a problem-orientated approach to integrate theories and methods. The authors tabulated the supporting evidence to produce a condensed but comprehensive information base, pooling data and experience from nine European countries, 13 institutions and more than 5500 patients. The consensus table summarises the current understanding regarding botulinum toxin treatment options in children with CP.
Heinen
Florian
F
Department of Paediatric Neurology and Developmental Neurology, Dr. von Hauner's Children's Hospital, University of Munich, Lindwurmstr. 4, D-80337 Munich, Germany. florian.heinen@med.uni-muenchen.de
Molenaers
Guy
G
Fairhurst
Charlie
C
Carr
Lucinda J
LJ
Desloovere
Kaat
K
Chaleat Valayer
Emmanuelle
E
Morel
Edith
E
Papavassiliou
Antigone S
AS
Tedroff
Kristina
K
Ignacio Pascual-Pascual
S
S
Bernert
Günther
G
Berweck
Steffen
S
Di Rosa
Guiseppe
G
Kolanowski
Elisabeth
E
Krägeloh-Mann
Ingeborg
I
D018726:Anti-Dyskinesia Agents / Q000592:standards / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000592:standards / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D005060:Europe; D006801:Humans
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins